← Return to Pancreatic Cancer Surgery Q&A w/ Dr. Stauffer on September 4

Discussion
Comment receiving replies
Profile picture for vlny2018 @vlny2018

The RMC-6236 is closed at Huntsman in Utah (close to where we live) and waiting for data and hopefully FDA approval. My husband is on Gem-Abr now, but it may not be working. He had to go off folfirinox because it may have been what was causing him to have bleeding ulcers. He had never had ulcers before. The other KRAS trials seem to be targeting specific mutations. His is KRAS G12V. But, we are trying to stay researching. My husband and I have stayed super active and eat a pretty strict diet. He is also trying intermittent fasting, which seems to be helping with energy.

Jump to this post


Replies to "The RMC-6236 is closed at Huntsman in Utah (close to where we live) and waiting for..."

I read that rmc6236 which is named as ras solute 302 in phase 3 was given the designation of FDA breakthrough therapy in late June of this year. All trials will be completed by the end of this year. FDA approval to occur in 2026. Do you have any idea when in 2026 this approval should be given?